Haleon (HLN) Competitors

Haleon (NYSE:HLN) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment, community ranking and earnings.

Does the media refer more to HLN or HUM?

In the previous week, Humana had 18 more articles in the media than Haleon. MarketBeat recorded 20 mentions for Humana and 2 mentions for Haleon. Haleon's average media sentiment score of 1.09 beat Humana's score of 0.28 indicating that Haleon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haleon	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	5 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders hold more shares of HLN or HUM?

6.7% of Haleon shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.3% of Humana shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is HLN or HUM a better dividend stock?

Haleon pays an annual dividend of $0.21 per share and has a dividend yield of 2.5%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.1%. Haleon pays out 70.0% of its earnings in the form of a dividend. Humana pays out 22.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Which has more risk & volatility, HLN or HUM?

Haleon has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500.

Is HLN or HUM more profitable?

Haleon has a net margin of 9.68% compared to Humana's net margin of 1.82%. Humana's return on equity of 17.76% beat Haleon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haleon	9.68%	13.17%	6.43%
Humana	1.82%	17.76%	5.63%

Does the MarketBeat Community believe in HLN or HUM?

Humana received 873 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 64.15% of users gave Humana an outperform vote while only 39.29% of users gave Haleon an outperform vote.

Company	Underperform	Outperform
Haleon	Outperform Votes 11 39.29%	Underperform Votes 17 60.71%
Humana	Outperform Votes 884 64.15%	Underperform Votes 494 35.85%

Do analysts rate HLN or HUM?

Humana has a consensus target price of $424.50, indicating a potential upside of 26.49%. Given Humana's higher probable upside, analysts clearly believe Humana is more favorable than Haleon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haleon	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Humana	0 Sell rating(s)	10 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.47

Which has preferable earnings & valuation, HLN or HUM?

Humana has higher revenue and earnings than Haleon. Humana is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haleon	$11.24B	3.35	$1.30B	$0.30	27.47
Humana	$106.37B	0.38	$2.49B	$16.06	20.90

Summary

Humana beats Haleon on 13 of the 20 factors compared between the two stocks.